Article
Germline Testing Data Validate Inferences of Mutational Status for Variants Detected From Tumor-Only Sequencing.
JCO precision oncology - 1 Jan 2021
Jalloul Nahed, Gomy Israel, Stokes Samantha, Gusev Alexander, Johnson Bruce E, Lindeman Neal I, Macconaill Laura, Ganesan Shridar, Garber Judy E, Khiabanian Hossein
Abstract excerpt
Pathogenic germline variants (PGVs) in cancer susceptibility genes are usually identified through germline testing of DNA from blood or saliva: their detection can affect treatment options and potential risk-reduction strategies for patient relatives. PGV can also be identified in tumor sequencing assays, which, when performed without patient-matched normal specimens, render determination of variants' germline or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
